In Kentucky, 70 or more people died from cocaine overdose in 2013 and 2014, up significantly from prior years.
Press conference announcing Dr. Wermeling's naloxone nasal spray Fast Track designation from the FDA.
A nasal spray of the anti-opioid drug naloxone, developed by Daniel Wermeling, has FDA fast-track designation.
